Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway

Author： Krejci Pavel   Pejchalova Katerina   Wilcox William  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.25, Iss.4, 2007-08, pp. : 391-395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades

By  

Current Pharmaceutical Design, Vol. 15, Iss. 21, 2009-07 ,pp. : 2471-2480

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 16, 2004-06 ,pp. : 1907-1914

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase

By Meoli David F.   White R. J.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 8, 2010-08 ,pp. : 830-839

NRC Research Press

Access to resources Recommend Favorite